T2 Biosystems' T2Bacteria Panel has been granted CE mark approval by European regulators. The panel, which will be released in Europe in the third quarter as part of the company's T2Sepsis Solution, operates on the company's T2Dx instrument and takes about 3.5 hours to deliver species-specific results of targeted bacterial infections using whole blood.
EU OKs bacterial panel from T2 Biosystems
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.